204139-61-7

Basic information

• Product Name: 4-(1-CBZ-PIPERIDIN-4-YL)-BUTYRIC ACID
• Synonyms: 4-Piperidinebutanoic acid, 1-[(phenylmethoxy)carbonyl]-
• CAS NO: 204139-61-7
• Molecular Formula: C17H23NO4
• Molecular Weight: 305.37
• Mol File: 204139-61-7.mol
• Article Data: 3

Chemical Properties

• Boiling Point: 480°Cat760mmHg
• Flash Point: 244.1°C
• Appearance: /
• Density: 1.169g/cm³
• Vapor Pressure: 5.04E-10mmHg at 25°C
• Refractive Index: 1.542
• CAS DataBase Reference: 4-(1-CBZ-PIPERIDIN-4-YL)-BUTYRIC ACID(CAS DataBase Reference)
• NIST Chemistry Reference: 4-(1-CBZ-PIPERIDIN-4-YL)-BUTYRIC ACID(204139-61-7)
• EPA Substance Registry System: 4-(1-CBZ-PIPERIDIN-4-YL)-BUTYRIC ACID(204139-61-7)

Safety Data

• Hazardous Substances Data: 204139-61-7(Hazardous Substances Data)

Usage

General Description

4-(1-CBZ-PIPERIDIN-4-YL)-BUTYRIC ACID is a chemical compound that contains a piperidine ring, a butyric acid moiety, and a carbobenzyloxy protecting group. It is often used in the synthesis of pharmaceuticals and as a building block for drug discovery. The piperidine ring is a common structural motif in many drugs and natural products, and the butyric acid moiety contributes to the compound's solubility and bioavailability. The carbobenzyloxy protecting group is used to protect reactive functional groups during chemical reactions, allowing for selective manipulation of the compound's structure. Overall, 4-(1-CBZ-PIPERIDIN-4-YL)-BUTYRIC ACID is a versatile compound with potential applications in drug development and chemical synthesis.

InChI:InChI=1/C17H23NO4/c19-16(20)8-4-7-14-9-11-18(12-10-14)17(21)22-13-15-5-2-1-3-6-15/h1-3,5-6,14H,4,7-13H2,(H,19,20)

Upstream product

• 501-53-1 benzyl chloroformate 
• 100-43-6 4-vinylpyridine 
• 105-53-3 diethyl malonate 

Relevant articles and documents

Enantioselective α-arylation of N-acyloxazolidinones with copper(II)-bisoxazoline catalysts and diaryliodonium salts

A new strategy for the catalytic enantioselective α-arylation of N-acyloxazolidinones with chiral copper(II)-bisoxazoline complexes and diaryliodonium salts is described. The mild catalytic conditions are operationally simple, produce valuable synthetic building blocks in excellent yields and enantioselectivities, and can be applied to the synthesis of important nonsteroidal anti-inflammatory agents and their analogues.

Process for the preparation of azacycloalkylakanoyl pseudotetrapeptides

This invention is directed to a process for preparing a pseudotetrapeptide of formula I or a salt or prodrug thereof wherein is optionally nitrogen protected azaheterocyclyl; is a single or double bond; q is 1-5; B is alkyl, cycloalkyl, cycloalkylalkyl, alkylcycloalkyl, alkylcycloalkylalkyl, aryl, aralkyl, alkylaryl, or alkylaralkyl; Q2 is H or a carboxylic acid protecting group; J is —H, alkyl, cycloalkyl, cycloalkylalkyl, alkylcycloalkyl, alkylcycloalkylalkyl, aryl, substituted aryl, aralkyl, substituted aralkyl; L is OR1, or NR1R2, where R1 and R2 are independently —H, alkyl, cycloalkyl, cycloalkylalkyl, alkylcycloalkyl, alkylcycloalkylalkyl, aryl, aralkyl, alkylaryl or alkylaralkyl; and p is 1 or 2 which comprises the coupling of two dipeptides or psuedopeptides.